nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—IL1B—schizophrenia	0.667	1	CbGaD
Minocycline—CYCS—pineal body—schizophrenia	0.0105	0.0893	CbGeAlD
Minocycline—CYCS—blood plasma—schizophrenia	0.00576	0.049	CbGeAlD
Minocycline—CASP3—blood plasma—schizophrenia	0.00493	0.042	CbGeAlD
Minocycline—IL1B—blood plasma—schizophrenia	0.00394	0.0336	CbGeAlD
Minocycline—Tetracycline—PRNP—schizophrenia	0.00355	1	CrCbGaD
Minocycline—SLC22A8—urine—schizophrenia	0.00336	0.0287	CbGeAlD
Minocycline—MMP9—blood plasma—schizophrenia	0.00328	0.028	CbGeAlD
Minocycline—CASP1—forebrain—schizophrenia	0.00328	0.0279	CbGeAlD
Minocycline—CYCS—forebrain—schizophrenia	0.00315	0.0269	CbGeAlD
Minocycline—CYCS—telencephalon—schizophrenia	0.0029	0.0247	CbGeAlD
Minocycline—CASP3—forebrain—schizophrenia	0.0027	0.023	CbGeAlD
Minocycline—CASP1—gonad—schizophrenia	0.00252	0.0214	CbGeAlD
Minocycline—CASP3—telencephalon—schizophrenia	0.00248	0.0212	CbGeAlD
Minocycline—CYCS—gonad—schizophrenia	0.00242	0.0206	CbGeAlD
Minocycline—CASP1—blood—schizophrenia	0.00219	0.0187	CbGeAlD
Minocycline—CASP1—midbrain—schizophrenia	0.00216	0.0184	CbGeAlD
Minocycline—IL1B—forebrain—schizophrenia	0.00216	0.0184	CbGeAlD
Minocycline—CYCS—blood—schizophrenia	0.00211	0.018	CbGeAlD
Minocycline—CYCS—midbrain—schizophrenia	0.00208	0.0177	CbGeAlD
Minocycline—CASP3—gonad—schizophrenia	0.00207	0.0177	CbGeAlD
Minocycline—IL1B—telencephalon—schizophrenia	0.00199	0.0169	CbGeAlD
Minocycline—VEGFA—telencephalon—schizophrenia	0.00195	0.0166	CbGeAlD
Minocycline—CASP1—endocrine gland—schizophrenia	0.0019	0.0162	CbGeAlD
Minocycline—CYCS—endocrine gland—schizophrenia	0.00183	0.0156	CbGeAlD
Minocycline—CASP3—blood—schizophrenia	0.00181	0.0154	CbGeAlD
Minocycline—CASP1—nervous system—schizophrenia	0.00178	0.0152	CbGeAlD
Minocycline—CASP1—central nervous system—schizophrenia	0.00171	0.0146	CbGeAlD
Minocycline—CYCS—nervous system—schizophrenia	0.00171	0.0146	CbGeAlD
Minocycline—CASP1—cerebellum—schizophrenia	0.00167	0.0143	CbGeAlD
Minocycline—CYCS—central nervous system—schizophrenia	0.00165	0.014	CbGeAlD
Minocycline—CYCS—cerebellum—schizophrenia	0.00161	0.0137	CbGeAlD
Minocycline—CASP3—endocrine gland—schizophrenia	0.00157	0.0133	CbGeAlD
Minocycline—CASP3—nervous system—schizophrenia	0.00147	0.0125	CbGeAlD
Minocycline—IL1B—blood—schizophrenia	0.00144	0.0123	CbGeAlD
Minocycline—IL1B—midbrain—schizophrenia	0.00143	0.0121	CbGeAlD
Minocycline—CASP3—central nervous system—schizophrenia	0.00141	0.012	CbGeAlD
Minocycline—CASP3—cerebellum—schizophrenia	0.00138	0.0118	CbGeAlD
Minocycline—CASP1—brain—schizophrenia	0.00136	0.0116	CbGeAlD
Minocycline—CYCS—brain—schizophrenia	0.00131	0.0111	CbGeAlD
Minocycline—IL1B—endocrine gland—schizophrenia	0.00125	0.0107	CbGeAlD
Minocycline—MMP9—blood—schizophrenia	0.0012	0.0102	CbGeAlD
Minocycline—IL1B—nervous system—schizophrenia	0.00117	0.00998	CbGeAlD
Minocycline—IL1B—central nervous system—schizophrenia	0.00113	0.00961	CbGeAlD
Minocycline—CASP3—brain—schizophrenia	0.00112	0.00955	CbGeAlD
Minocycline—VEGFA—cerebellum—schizophrenia	0.00108	0.00924	CbGeAlD
Minocycline—MMP9—endocrine gland—schizophrenia	0.00104	0.00889	CbGeAlD
Minocycline—SLC22A11—endocrine gland—schizophrenia	0.000989	0.00842	CbGeAlD
Minocycline—MMP9—nervous system—schizophrenia	0.000977	0.00832	CbGeAlD
Minocycline—SLC22A7—endocrine gland—schizophrenia	0.000965	0.00822	CbGeAlD
Minocycline—ALOX5—blood—schizophrenia	0.000951	0.0081	CbGeAlD
Minocycline—MMP9—central nervous system—schizophrenia	0.00094	0.00801	CbGeAlD
Minocycline—IL1B—brain—schizophrenia	0.000896	0.00763	CbGeAlD
Minocycline—VEGFA—brain—schizophrenia	0.000881	0.0075	CbGeAlD
Minocycline—ALOX5—endocrine gland—schizophrenia	0.000825	0.00703	CbGeAlD
Minocycline—ALOX5—nervous system—schizophrenia	0.000772	0.00658	CbGeAlD
Minocycline—MMP9—brain—schizophrenia	0.000746	0.00636	CbGeAlD
Minocycline—ALOX5—central nervous system—schizophrenia	0.000743	0.00633	CbGeAlD
Minocycline—ALOX5—cerebellum—schizophrenia	0.000727	0.00619	CbGeAlD
Minocycline—SLC22A7—brain—schizophrenia	0.000691	0.00588	CbGeAlD
Minocycline—SLC22A6—brain—schizophrenia	0.000667	0.00568	CbGeAlD
Minocycline—SLC22A8—blood—schizophrenia	0.000643	0.00548	CbGeAlD
Minocycline—ALOX5—brain—schizophrenia	0.00059	0.00503	CbGeAlD
Minocycline—SLC22A8—nervous system—schizophrenia	0.000522	0.00445	CbGeAlD
Minocycline—SLC22A8—central nervous system—schizophrenia	0.000503	0.00428	CbGeAlD
Minocycline—SLC22A8—brain—schizophrenia	0.000399	0.0034	CbGeAlD
Minocycline—VEGFA—Signaling Pathways—PPP1R1B—schizophrenia	4.02e-05	0.000189	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—MEF2C—schizophrenia	4.01e-05	0.000189	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GRM5—schizophrenia	3.99e-05	0.000188	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—AKT1—schizophrenia	3.98e-05	0.000188	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—ATP2A2—schizophrenia	3.97e-05	0.000187	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TLE3—schizophrenia	3.87e-05	0.000182	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CYP1A2—schizophrenia	3.81e-05	0.00018	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—SLC6A3—schizophrenia	3.78e-05	0.000178	CbGpPWpGaD
Minocycline—CYCS—Metabolism—TH—schizophrenia	3.76e-05	0.000177	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NGEF—schizophrenia	3.74e-05	0.000176	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FZD3—schizophrenia	3.74e-05	0.000176	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—SLC6A1—schizophrenia	3.72e-05	0.000175	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-E—schizophrenia	3.69e-05	0.000174	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NTS—schizophrenia	3.66e-05	0.000172	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCK—schizophrenia	3.65e-05	0.000172	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—AKT1—schizophrenia	3.61e-05	0.00017	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	3.59e-05	0.000169	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—EP300—schizophrenia	3.58e-05	0.000169	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—GSK3B—schizophrenia	3.57e-05	0.000168	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PDE4B—schizophrenia	3.56e-05	0.000168	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—EP300—schizophrenia	3.56e-05	0.000168	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TAAR6—schizophrenia	3.51e-05	0.000166	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GRM2—schizophrenia	3.51e-05	0.000166	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FES—schizophrenia	3.51e-05	0.000166	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PPP3CC—schizophrenia	3.51e-05	0.000166	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—PLA2G4A—schizophrenia	3.51e-05	0.000165	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCKAR—schizophrenia	3.5e-05	0.000165	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MEF2C—schizophrenia	3.48e-05	0.000164	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—AKT1—schizophrenia	3.44e-05	0.000162	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GRM3—schizophrenia	3.44e-05	0.000162	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RTN4—schizophrenia	3.44e-05	0.000162	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RGS4—schizophrenia	3.44e-05	0.000162	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—TNF—schizophrenia	3.42e-05	0.000161	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ADORA2A—schizophrenia	3.4e-05	0.00016	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HTR6—schizophrenia	3.38e-05	0.000159	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GAPDH—schizophrenia	3.37e-05	0.000159	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CLOCK—schizophrenia	3.34e-05	0.000157	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—ABCB1—schizophrenia	3.34e-05	0.000157	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—APOE—schizophrenia	3.33e-05	0.000157	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—ATP2A2—schizophrenia	3.31e-05	0.000156	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—YWHAZ—schizophrenia	3.3e-05	0.000155	CbGpPWpGaD
Minocycline—IL1B—Immune System—PRL—schizophrenia	3.3e-05	0.000155	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	3.29e-05	0.000155	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MAG—schizophrenia	3.26e-05	0.000154	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FGA—schizophrenia	3.26e-05	0.000154	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—TPH2—schizophrenia	3.25e-05	0.000153	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CACNB2—schizophrenia	3.25e-05	0.000153	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—AKT1—schizophrenia	3.25e-05	0.000153	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NGEF—schizophrenia	3.25e-05	0.000153	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—DPYD—schizophrenia	3.2e-05	0.000151	CbGpPWpGaD
Minocycline—CYCS—Metabolism—COMT—schizophrenia	3.2e-05	0.000151	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GSTP1—schizophrenia	3.18e-05	0.00015	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—AKT1—schizophrenia	3.18e-05	0.00015	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NTS—schizophrenia	3.18e-05	0.00015	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—SLC6A3—schizophrenia	3.18e-05	0.00015	CbGpPWpGaD
Minocycline—CYCS—Metabolism—MAOA—schizophrenia	3.17e-05	0.00015	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NPY—schizophrenia	3.17e-05	0.00015	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NOTCH4—schizophrenia	3.17e-05	0.00015	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ATP2A2—schizophrenia	3.17e-05	0.00015	CbGpPWpGaD
Minocycline—CASP1—Immune System—GSK3B—schizophrenia	3.15e-05	0.000148	CbGpPWpGaD
Minocycline—CASP1—Immune System—FOS—schizophrenia	3.13e-05	0.000147	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—TP53—schizophrenia	3.1e-05	0.000146	CbGpPWpGaD
Minocycline—IL1B—Immune System—S100B—schizophrenia	3.07e-05	0.000145	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—OXT—schizophrenia	3.06e-05	0.000144	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HTR1B—schizophrenia	3.06e-05	0.000144	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—ABCB1—schizophrenia	3.03e-05	0.000143	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ABCB1—schizophrenia	3.01e-05	0.000142	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GRM3—schizophrenia	2.99e-05	0.000141	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RTN4—schizophrenia	2.99e-05	0.000141	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RGS4—schizophrenia	2.99e-05	0.000141	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CHRM1—schizophrenia	2.98e-05	0.000141	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CACNA1C—schizophrenia	2.97e-05	0.00014	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HTR1A—schizophrenia	2.95e-05	0.000139	CbGpPWpGaD
Minocycline—IL1B—Immune System—ERBB4—schizophrenia	2.94e-05	0.000138	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—GSK3B—schizophrenia	2.93e-05	0.000138	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HTR6—schizophrenia	2.93e-05	0.000138	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PLA2G4A—schizophrenia	2.92e-05	0.000138	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GSTM1—schizophrenia	2.92e-05	0.000138	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—schizophrenia	2.91e-05	0.000137	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL3RA—schizophrenia	2.91e-05	0.000137	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NPS—schizophrenia	2.9e-05	0.000137	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PIK3C2A—schizophrenia	2.9e-05	0.000137	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—APOA1—schizophrenia	2.85e-05	0.000134	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—DRD1—schizophrenia	2.85e-05	0.000134	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HTR2C—schizophrenia	2.85e-05	0.000134	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NRG3—schizophrenia	2.84e-05	0.000134	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TLE1—schizophrenia	2.84e-05	0.000134	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MAG—schizophrenia	2.83e-05	0.000133	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GFAP—schizophrenia	2.8e-05	0.000132	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GRM5—schizophrenia	2.77e-05	0.000131	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NTRK2—schizophrenia	2.77e-05	0.000131	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—EP300—schizophrenia	2.77e-05	0.00013	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—DRD3—schizophrenia	2.76e-05	0.00013	CbGpPWpGaD
Minocycline—IL1B—Immune System—NRG1—schizophrenia	2.71e-05	0.000128	CbGpPWpGaD
Minocycline—IL1B—Immune System—MEF2C—schizophrenia	2.69e-05	0.000127	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TLE3—schizophrenia	2.69e-05	0.000127	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—DRD4—schizophrenia	2.68e-05	0.000126	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—SLC6A3—schizophrenia	2.65e-05	0.000125	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—APOA1—schizophrenia	2.63e-05	0.000124	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—AKT1—schizophrenia	2.61e-05	0.000123	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—AKT1—schizophrenia	2.6e-05	0.000123	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—SNAP25—schizophrenia	2.6e-05	0.000123	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CYP2D6—schizophrenia	2.6e-05	0.000123	CbGpPWpGaD
Minocycline—IL1B—Immune System—YWHAZ—schizophrenia	2.6e-05	0.000122	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CHRM1—schizophrenia	2.59e-05	0.000122	CbGpPWpGaD
Minocycline—CYCS—Metabolism—MTHFR—schizophrenia	2.58e-05	0.000122	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	2.57e-05	0.000121	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CNR1—schizophrenia	2.56e-05	0.00012	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—GSK3B—schizophrenia	2.55e-05	0.00012	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—ABCB1—schizophrenia	2.54e-05	0.00012	CbGpPWpGaD
Minocycline—IL1B—Immune System—ERBB3—schizophrenia	2.54e-05	0.00012	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCK—schizophrenia	2.54e-05	0.00012	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL3RA—schizophrenia	2.52e-05	0.000119	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HTR7—schizophrenia	2.49e-05	0.000118	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—DRD2—schizophrenia	2.49e-05	0.000118	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PDE4B—schizophrenia	2.47e-05	0.000117	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TLE1—schizophrenia	2.46e-05	0.000116	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NRG3—schizophrenia	2.46e-05	0.000116	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GFAP—schizophrenia	2.43e-05	0.000115	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCKAR—schizophrenia	2.43e-05	0.000115	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GRM5—schizophrenia	2.41e-05	0.000113	CbGpPWpGaD
Minocycline—CYCS—Metabolism—APOE—schizophrenia	2.41e-05	0.000113	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—APOA1—schizophrenia	2.39e-05	0.000113	CbGpPWpGaD
Minocycline—CYCS—Metabolism—APOA1—schizophrenia	2.38e-05	0.000112	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADORA2A—schizophrenia	2.36e-05	0.000111	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PRL—schizophrenia	2.35e-05	0.000111	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CYP1A2—schizophrenia	2.35e-05	0.000111	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TLE3—schizophrenia	2.33e-05	0.00011	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL1B—schizophrenia	2.32e-05	0.000109	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—TH—schizophrenia	2.32e-05	0.000109	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FGA—schizophrenia	2.26e-05	0.000107	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NOTCH4—schizophrenia	2.2e-05	0.000104	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NPY—schizophrenia	2.2e-05	0.000104	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ATP2A2—schizophrenia	2.2e-05	0.000104	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCK—schizophrenia	2.2e-05	0.000104	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—S100B—schizophrenia	2.19e-05	0.000103	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—AKT1—schizophrenia	2.18e-05	0.000103	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	2.17e-05	0.000102	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—AKT1—schizophrenia	2.15e-05	0.000101	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PDE4B—schizophrenia	2.15e-05	0.000101	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—OXT—schizophrenia	2.13e-05	0.0001	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HTR1B—schizophrenia	2.13e-05	0.0001	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—ABCB1—schizophrenia	2.12e-05	0.0001	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCKAR—schizophrenia	2.11e-05	9.95e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ERBB4—schizophrenia	2.1e-05	9.89e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—EP300—schizophrenia	2.07e-05	9.77e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADORA2A—schizophrenia	2.05e-05	9.65e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HTR1A—schizophrenia	2.05e-05	9.64e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NPS—schizophrenia	2.01e-05	9.5e-05	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—APOA1—schizophrenia	2.01e-05	9.47e-05	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—TP53—schizophrenia	1.98e-05	9.34e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—DRD1—schizophrenia	1.98e-05	9.31e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HTR2C—schizophrenia	1.98e-05	9.31e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PLA2G4A—schizophrenia	1.97e-05	9.3e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—COMT—schizophrenia	1.97e-05	9.29e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—GSK3B—schizophrenia	1.97e-05	9.28e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FGA—schizophrenia	1.96e-05	9.25e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GSTP1—schizophrenia	1.96e-05	9.24e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—MAOA—schizophrenia	1.96e-05	9.22e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—FOS—schizophrenia	1.96e-05	9.22e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NRG1—schizophrenia	1.94e-05	9.13e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—EP300—schizophrenia	1.93e-05	9.1e-05	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—AKT1—schizophrenia	1.93e-05	9.09e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NTRK2—schizophrenia	1.92e-05	9.06e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MEF2C—schizophrenia	1.92e-05	9.05e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—DRD3—schizophrenia	1.91e-05	9.02e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NPY—schizophrenia	1.91e-05	9.02e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NOTCH4—schizophrenia	1.91e-05	9.02e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ATP2A2—schizophrenia	1.91e-05	9.02e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—EP300—schizophrenia	1.9e-05	8.94e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—DRD4—schizophrenia	1.86e-05	8.76e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ABCB1—schizophrenia	1.86e-05	8.75e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—YWHAZ—schizophrenia	1.85e-05	8.74e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HTR1B—schizophrenia	1.84e-05	8.7e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—OXT—schizophrenia	1.84e-05	8.7e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ERBB3—schizophrenia	1.81e-05	8.55e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GSTM1—schizophrenia	1.8e-05	8.49e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PLA2G4A—schizophrenia	1.8e-05	8.49e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HTR1A—schizophrenia	1.78e-05	8.37e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CNR1—schizophrenia	1.77e-05	8.36e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NPS—schizophrenia	1.75e-05	8.25e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HTR2A—schizophrenia	1.75e-05	8.23e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HTR7—schizophrenia	1.73e-05	8.16e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—DRD2—schizophrenia	1.73e-05	8.16e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HTR2C—schizophrenia	1.72e-05	8.09e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—DRD1—schizophrenia	1.72e-05	8.09e-05	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—APOA1—schizophrenia	1.68e-05	7.9e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—EP300—schizophrenia	1.68e-05	7.9e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NTRK2—schizophrenia	1.67e-05	7.87e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—DRD3—schizophrenia	1.66e-05	7.83e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—EP300—schizophrenia	1.64e-05	7.75e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PRL—schizophrenia	1.63e-05	7.7e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—APOE—schizophrenia	1.62e-05	7.65e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—DRD4—schizophrenia	1.61e-05	7.6e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—APOA1—schizophrenia	1.6e-05	7.56e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—MTHFR—schizophrenia	1.59e-05	7.51e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TNF—schizophrenia	1.57e-05	7.39e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ESR1—schizophrenia	1.55e-05	7.31e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CNR1—schizophrenia	1.54e-05	7.26e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—S100B—schizophrenia	1.52e-05	7.18e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HTR7—schizophrenia	1.5e-05	7.08e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—DRD2—schizophrenia	1.5e-05	7.08e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—APOE—schizophrenia	1.48e-05	6.99e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—APOA1—schizophrenia	1.47e-05	6.91e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ERBB4—schizophrenia	1.46e-05	6.87e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PRL—schizophrenia	1.42e-05	6.69e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GSK3B—schizophrenia	1.41e-05	6.63e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—EP300—schizophrenia	1.37e-05	6.46e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PLA2G4A—schizophrenia	1.37e-05	6.46e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TNF—schizophrenia	1.36e-05	6.41e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NRG1—schizophrenia	1.34e-05	6.34e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MEF2C—schizophrenia	1.33e-05	6.28e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—S100B—schizophrenia	1.32e-05	6.23e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—EP300—schizophrenia	1.29e-05	6.11e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—YWHAZ—schizophrenia	1.29e-05	6.07e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ERBB4—schizophrenia	1.26e-05	5.96e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ERBB3—schizophrenia	1.26e-05	5.94e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—AKT1—schizophrenia	1.25e-05	5.9e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HTR2A—schizophrenia	1.21e-05	5.71e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PLA2G4A—schizophrenia	1.19e-05	5.6e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TP53—schizophrenia	1.18e-05	5.55e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NRG1—schizophrenia	1.17e-05	5.5e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—AKT1—schizophrenia	1.17e-05	5.5e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MEF2C—schizophrenia	1.16e-05	5.45e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—APOE—schizophrenia	1.13e-05	5.31e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—YWHAZ—schizophrenia	1.12e-05	5.27e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—APOA1—schizophrenia	1.11e-05	5.25e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ERBB3—schizophrenia	1.09e-05	5.15e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ESR1—schizophrenia	1.08e-05	5.07e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HTR2A—schizophrenia	1.05e-05	4.96e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—AKT1—schizophrenia	1.01e-05	4.78e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—AKT1—schizophrenia	9.94e-06	4.68e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—APOE—schizophrenia	9.78e-06	4.61e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GSK3B—schizophrenia	9.76e-06	4.6e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—APOA1—schizophrenia	9.67e-06	4.56e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ESR1—schizophrenia	9.34e-06	4.4e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—EP300—schizophrenia	9.25e-06	4.36e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GSK3B—schizophrenia	8.47e-06	3.99e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—EP300—schizophrenia	8.45e-06	3.98e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—AKT1—schizophrenia	8.28e-06	3.91e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—AKT1—schizophrenia	7.83e-06	3.69e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TP53—schizophrenia	6.62e-06	3.12e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—EP300—schizophrenia	6.42e-06	3.03e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AKT1—schizophrenia	5.59e-06	2.64e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EP300—schizophrenia	5.57e-06	2.63e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—AKT1—schizophrenia	5.1e-06	2.41e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TP53—schizophrenia	4.6e-06	2.17e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TP53—schizophrenia	3.99e-06	1.88e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AKT1—schizophrenia	3.88e-06	1.83e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AKT1—schizophrenia	3.37e-06	1.59e-05	CbGpPWpGaD
